-
EP3043785
European procedure
Extract from the Register of European Patents
EP Citations: EP3043785
| Cited in | International search | Type: | Patent literature | Publication No.: | US2012225949
[X] (PAPALOS DEMITRI et al.) | Type: | Patent literature | Publication No.: | WO2011020061
[X] (PAPALOS DEMITRI et al.) | Type: | Non-patent literature | Publication information: | [X] A. SCHMIDT ET AL: "Cerebral physiological responses to bolus injection of racemic, S(+)- or R(-)-ketamine in the pig", ACTA ANAESTHESIOLOGICA SCANDINAVICA, vol. 49, no. 10, 13 October 2005 (2005-10-13), pages 1436 - 1442, XP055158242, ISSN: 0001-5172, DOI: 10.1111/j.1399-6576.2005.00838.x | DOI: | http://dx.doi.org/10.1111/j.1399-6576.2005.00838.x | Type: | Non-patent literature | Publication information: | [XI] SCOTT A. IRWIN ET AL: "Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial", JOURNAL OF PALLIATIVE MEDICINE, vol. 16, no. 8, 1 August 2013 (2013-08-01), pages 958 - 965, XP055158543, ISSN: 1096-6218, DOI: 10.1089/jpm.2012.0617 | DOI: | http://dx.doi.org/10.1089/jpm.2012.0617 | Type: | Non-patent literature | Publication information: | [XDI] R.PAUL, N.SCHAAFF,F.PADBERG,HANS-JRGEN MLLER,THOMAS FRODL: "Comparison of racemic ketamine and S-Ketamine in treatment-resistant major depression: Report of two cases", THE WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, vol. 10, no. 3, 1 January 2009 (2009-01-01), U.K., pages 241 - 244, XP002733798 | DOI: | http://dx.doi.org/10.1080/15622970701714370 | Type: | Non-patent literature | Publication information: | [XI] WOMBLE, ARTHUR L.: "AANA Journal - April 2013 Volume 81 Number 2 : Effects of Ketamine on Major Depressive Disorder in a Patient With Posttraumatic Stress Disorder", 1 April 2013 (2013-04-01), XP055158740, Retrieved from the Internet | Type: | Non-patent literature | Publication information: | [XPI] JI-CHUN ZHANG ET AL: "R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine", PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, vol. 116, 1 January 2014 (2014-01-01), pages 137 - 141, XP055158236, ISSN: 0091-3057, DOI: 10.1016/j.pbb.2013.11.033 | DOI: | http://dx.doi.org/10.1016/j.pbb.2013.11.033 | Cited in | by applicant | Type: | Patent literature | Publication No.: | WO2007111880
| Type: | Patent literature | Publication No.: | US6040479
| Type: | Non-patent literature | Publication information: | DINIZ BD; BUTTERS MA; ALBERT SM; DEW MA; REYNOLDS CF: "Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies", B. J. PSYCHIATRY, vol. 202, 2013, pages 329 - 335 | Type: | Non-patent literature | Publication information: | HASHIMOTO K: "Emerging role of glutamate in the pathophysiology of major depressive disorder", BRAIN RES. REV., vol. 61, 2009, pages 105 - 23, XP026669126, DOI: doi:10.1016/j.brainresrev.2009.05.005 | DOI: | http://dx.doi.org/10.1016/j.brainresrev.2009.05.005 | Type: | Non-patent literature | Publication information: | BERMAN RM; CAPPIELLO A; ANAND A; OREN DA; HENINGER GR; CHARNEY DS; KRYSTAL JH: "Antidepressant effects of ketamine in depressed patients", BIOL. PSYCHIATRY, vol. 47, 2000, pages 351 - 4, XP002565719, DOI: doi:10.1016/S0006-3223(99)00230-9 | DOI: | http://dx.doi.org/10.1016/S0006-3223(99)00230-9 | Type: | Non-patent literature | Publication information: | ZARATE CA, JR; SINGH JB; CARLSON PJ; BRUTSCHE NE; AMELI R; LUCKENBAUGH BA; CHARNEY DS; MANJI HK: "A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression", ARCH. GEN. PSYCHIATRY, vol. 63, 2006, pages 856 - 64, XP002565718, DOI: doi:10.1001/archpsyc.63.8.856 | DOI: | http://dx.doi.org/10.1001/archpsyc.63.8.856 | Type: | Non-patent literature | Publication information: | DIAZGRANADOS N; IBRAHIM L; BRUTSCHE NE; NEWBERG A; KRONSTEIN P; KHALIFE S; KAMMERER WA; QUEZADO Z; LUCKENBAUGH DA; SALVADORE G: "A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression", ARCH. GEN. PSYCHIATRY, vol. 67, 2010, pages 793 - 802 | Type: | Non-patent literature | Publication information: | BLOCH MH; WASYLINK S; LANDEROS-WEISENBERGER A; PANZA KE; BILLINGSLEA E; LECKMAN JF; KRYSTAL JH; BHAGWAGAR Z; SANACORA G; PITTENGER: "Effects of ketamine in treatment-refractory obsessive-compulsive disorder", BIOL. PSYCHIATRY, vol. 72, no. 11, 2012, pages 964 - 970, XP055216625, DOI: doi:10.1016/j.biopsych.2012.05.028 | DOI: | http://dx.doi.org/10.1016/j.biopsych.2012.05.028 | Type: | Non-patent literature | Publication information: | RODRIGUEZ CI; KEGELES LS; LEVINSONA; FENG T; MARCUS SM; VERMES D; FLOOD P; SIMPSON HB: "Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept", NEUROPSYCHOPHARMACOLOGY, vol. 38, 2013, pages 2475 - 83 | Type: | Non-patent literature | Publication information: | FEDER A; PARIDES MK; MURROUGH JW; PEREZ AM; MORGAN JE; SAXENA S; KIRKWOOD K; AAN HET ROT M; LAPIDUS KA; WAN LB: "Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial", JAMA PSYCHIATRY, vol. 71, 2014, pages 681 - 688, XP009186290 | Type: | Non-patent literature | Publication information: | DIAZGRANADOS N; IBRAHIM LA; BRUTSCHE NE; AMELI R; HENTER ID; LUCKENBAUGH DA; MACHADO-VIEIRA R; ZARATE CA JR: "Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder", J CLIN. PSYCHIATRY, vol. 71, no. 12, 2010, pages 1605 - 11, XP008161411, DOI: doi:doi:10.4088/JCP.09m05327blu | DOI: | http://dx.doi.org/doi:10.4088/JCP.09m05327blu | Type: | Non-patent literature | Publication information: | WINK LK1; O'MELIA AM; SHAFFER RC; PEDAPATI E; FRIEDMANN K; SCHAEFER T; ERICKSON CA: "Intranasal ketamine treatment in an adult with autism spectrum disorder", J CLIN. PSYCHIATRY, vol. 75, no. 8, 2014, pages 835 - 6, XP009183695, DOI: doi:10.4088/JCP.13cr08917 | DOI: | http://dx.doi.org/10.4088/JCP.13cr08917 | Type: | Non-patent literature | Publication information: | KRYSTAL JH; SANACORA G; DUMAN RS: "Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond", BIOL. PSYCHIATRY, vol. 73, 2013, pages 1133 - 41, XP028557119, DOI: doi:10.1016/j.biopsych.2013.03.026 | DOI: | http://dx.doi.org/10.1016/j.biopsych.2013.03.026 | Type: | Non-patent literature | Publication information: | DOMINO EF: "Taming the ketamine tiger", ANESTHESIOLOGY, vol. 113, 1965, pages 678 - 86 | Type: | Non-patent literature | Publication information: | VOLLENWEIDER FX; LEENDERS KL; OEYE I; HELL D; ANGST J: "Differential psychopathology and patterns of cerebral glucose utilization produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET", EUR. NEUROPSYCHOPHARMACOL., vol. 7, September 1997 (1997-09-01), pages 25 - 38 | Type: | Non-patent literature | Publication information: | PAUL R; SCHAAFF N; PADBERG F; MOELLER HJ; FRODL T: "Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report from two cases", WORLD J. BIOL.PSYCHIATRY, vol. 10, 2009, pages 241 - 244, XP002733798, DOI: doi:10.1080/15622970701714370 | DOI: | http://dx.doi.org/10.1080/15622970701714370 | Type: | Non-patent literature | Publication information: | PASLAKIS G; GILLES M; MEYER-LINDENBERG A; DEUSCHLE M: "Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series", PHARMACOPSYCHIATRY, vol. 43, 2010, pages 33 - 35, XP008161418, DOI: doi:10.1055/s-0029-1237375 | DOI: | http://dx.doi.org/10.1055/s-0029-1237375 | Type: | Non-patent literature | Publication information: | IRWIN SA; IGLEWICZ A; NELESEN RA; LO JY; CARR CH; ROMERO SD; LLOYD LS: "Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: A 28-day open-label proof-of-concept trial", J. PALLIAT. MED., vol. 16, 2013, pages 958 - 965, XP055158543, DOI: doi:10.1089/jpm.2012.0617 | DOI: | http://dx.doi.org/10.1089/jpm.2012.0617 | Type: | Non-patent literature | Publication information: | LAPIDUS KA; LEVITCH CF; PEREZ AM; BRALLIER JW; PARIDES MK; SOLEIMANI L; FEDER A; IOSIFESCU DV; CHARNEY DS; MURROUGH JW: "A randomized controlled trial of intranasal ketamine in major depressive disorder", BIOL. PSYCHIATRY, 3 April 2014 (2014-04-03) | Type: | Non-patent literature | Publication information: | LI SX; FUJITA Y; ZHANG JC; REN Q; ISHIMA T; WU J; HASHIMOTO K: "Role of the NMDA receptor in cognitive deficits, anxiety and depressive-like behavior in juvenile and adult mice after neonatal dexamethasone exposure", NEUROBIOL. DIS., vol. 62, 2014, pages 124 - 134, XP055432646, DOI: doi:10.1016/j.nbd.2013.09.004 | DOI: | http://dx.doi.org/10.1016/j.nbd.2013.09.004 | Type: | Non-patent literature | Publication information: | GOLDEN SA; COVINGTON HE, III; BERTON O; RUSSO SJ: "A standardized protocol for repeated social defeat stress in mice", NAT. PROTOC., vol. 6, 2011, pages 1183 - 1191 | Type: | Non-patent literature | Publication information: | "Remington's Pharmaceutical Sciences", 1970, MACK PUBLISHING COMPANY |